Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

solco healthcare llc - entecavir anhydrous (unii: nnu2o4609d) (entecavir anhydrous - unii:nnu2o4609d) - entecavir anhydrous 0.5 mg - entecavir is indicated for the treatment of chronic hepatitis b virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (alt or ast) or histologically active disease. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to entecavir during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary prospective pregnancy data from the apr are not sufficient to adequately assess the risk of birth defects, miscarriage or adverse maternal or fetal outcomes. entecavir use during pregnancy has been evaluated in a limited number of individuals reported to the apr and the number of exposures to entecavir is insufficient to make a risk assessment compared to a reference population. the estimated background rate for major birth

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

solco healthcare llc - clonazepam (unii: 5pe9fde8gb) (clonazepam - unii:5pe9fde8gb) - clonazepam is useful alone or as an adjunct in the treatment of the lennox-gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. in patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful. some loss of effect may occur during the course of clonazepam treatment (see precautions: loss of effect ). clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in dsm-v. panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks. the efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the dsm-iiir category of panic disorder (see clinical pharmacology: clinical trials ). panic disorder (dsm-v) is characterized by recurrent unexpected pan

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

siddha flower essences llc - ceratostigma willmottianum flower (unii: tp69j995tw) (ceratostigma willmottianum flower - unii:tp69j995tw), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), larix decidua flowering top (unii: 9umz642257) (larix decidua flowering top - unii:9umz642257), mimulus guttatus flowering top (unii: 192426i5ju) (mimulus guttatus flowering top - unii:192426i5ju), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) ( - each dose contains equal parts of: ceratostigma willmottianum, flos (cerato) 5x hpus...........lack of confidence in one's intuition kali sulph 6x hpus........................................................hair falling out; dandruff; bald spots larix decidua, flow (larch) 5x hpus.................................feeling inferior to others mimulus guttatus, flos (mimulus) 5x hpus.......................shyness; timidity; well-defined fears nat mur 6x hpus...........................................................hear falling out; dandruff; itching nat phos 6x hpus.........................................................hair falls out; tension in scalp silicea 12x hpus...........................................................hair falling out - temporarily relieves symptoms of - hair falling out - dandruff - itchy scalp - tension in scalp - not trusting one's intuition

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

bayer healthcare llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle - single-dose therapy: baytril® 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-day therapy: baytril® 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: baytril® 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. baytril® 100 is indicated for the control of colibacillosis in groups or pens of weaned p

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

quallent pharmaceuticals health llc - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release tablets (xl) are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with mdd. the efficacy of the sustained-release formulation of bupropion in the maintenance treatment of mdd was established in a long-term (up to 44 weeks), placebo-controlled trial in patients who had responded to bupropion in an 8-week study of acute treatment [see clinical studies (14.1)]. bupropion hydrochloride extended-release tablets (xl) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (sad). the efficacy of bupropion hydrochloride extended-release tablets (xl) in the prevention of seasonal major depressive episodes was established in 3 placebo-controlled trials i

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - injection, powder, for solution - 500 mg/vial - mycophenolate mofetil 500 mg/vial

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - tablet, film coated - 500 mg - mycophenolate mofetil 500 mg

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - capsule - 250 mg - mycophenolate mofetil 250 mg

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. - mycophenolate mofetil - capsules - 250mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

rising health, llc - gemfibrozil (unii: q8x02027x3) (gemfibrozil - unii:q8x02027x3) - gemfibrozil 600 mg - gemfibrozil tablets, usp are indicated as adjunctive therapy to diet for: - treatment of adult patients with very high elevations of serum triglyceride levels (types iv and v hyperlipidemia) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. patients who present such risk typically have serum triglycerides over 2000 mg/dl and have elevations of vldl-cholesterol as well as fasting chylomicrons (type v hyperlipidemia). subjects who consistently have total serum or plasma triglycerides below 1000 mg/dl are unlikely to present a risk of pancreatitis. gemfibrozil tablets, usp therapy may be considered for those subjects with triglyceride elevations between 1000 and 2000 mg/dl who have a history of pancreatitis or of recurrent abdominal pain typical of pancreatitis. it is recognized that some type iv patients with triglycerides under 1000 mg/dl may, through dietary or alcoholic indiscretion, convert to a type v pattern with massive triglyceride eleva